Literature DB >> 34173967

Synthesis of Tellurium Oxide (TeO2) Nanorods and Nanoflakes and Evaluation of Its Efficacy Against Leishmania major In Vitro and In Vivo.

Pooya Tavakoli1, Fatemeh Ghaffarifar2, Hamid Delavari3, Amir KarimiPourSaryazdi1, Mohammad Saaid Dayer1, Vahid Nasiri4, Salimeh Ahmadi3.   

Abstract

PURPOSE: Today, the use of natural products and nanostructures has increased. Given the reports on beneficial effects of various organotellurane compounds on types of visceral leishmaniasis, we decided to investigate the effect of TeO2 NPs on Leishmania major (L. major). Tellurium can cause cell apoptosis in cancer cells without activating the caspase-pathway.
METHODS: TeO2 NPs at first synthesized and the structure was checked by XRD, SEM and EDS tests. The cytotoxic effect of TeO2 NPs against L. major promastigotes, amastigotes and macrophages was assessed by MTT test or counting. The possible apoptosis of L. major by TeO2 NPs was evaluated by flow cytometry test. For in vivo assay, the lesions of infected BALB/c mice with L. major promastigotes were treated with TeO2 NPs, then the lesion size and survival rate were evaluated.
RESULTS: The synthesis of TeO2 with tetragonal structure was confirmed by XRD. The combination of nanorods and nanoflakes and the presence of Te were proven by SEM and EDS, respectively. According the effects of nanoparticle on promastigotes and amastigotes, the IC50 values of TeO2 after 72 h of incubation were 15.13 and 52.22 µg/ml, respectively. TeO2 NPs induced apoptosis in about 41% of promastigotes. The ulcer greatly healed and survival rate was higher in treated mice compared to those in control group.
CONCLUSION: Based on the data, favorable anti-leishmanial properties were observed by using TeO2 NPs. TeO2 NPs have cytotoxic impacts on L. major promastigotes and amastigotes in vitro and in vivo and may be regarded as a therapy option.
© 2021. Witold Stefański Institute of Parasitology, Polish Academy of Sciences.

Entities:  

Keywords:  BALB/c; In vitro; In vivo; Leishmania major; Organotellurane

Mesh:

Substances:

Year:  2021        PMID: 34173967     DOI: 10.1007/s11686-021-00445-w

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  30 in total

1.  Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.

Authors:  S Sundar; D K More; M K Singh; V P Singh; S Sharma; A Makharia; P C Kumar; H W Murray
Journal:  Clin Infect Dis       Date:  2000-10       Impact factor: 9.079

2.  Silver nanoparticles and electroporation: Their combinational effect on Leishmania major.

Authors:  Elham Dolat; Omid Rajabi; Samaneh Soudmand Salarabadi; Sajedeh Yadegari-Dehkordi; Ameneh Sazgarnia
Journal:  Bioelectromagnetics       Date:  2015-11-19       Impact factor: 2.010

3.  Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies.

Authors:  Azar Shokri; Mahdi Abastabar; Masoud Keighobadi; Saeed Emami; Mahdi Fakhar; Saeed Hosseini Teshnizi; Koichi Makimura; Ali Rezaei-Matehkolaei; Hassan Mirzaei
Journal:  J Glob Antimicrob Resist       Date:  2018-05-21       Impact factor: 4.035

Review 4.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

5.  Nano-based antileishmanial agents: a toxicological study on nanoparticles for future treatment of cutaneous leishmaniasis.

Authors:  Ali Jebali; Bahram Kazemi
Journal:  Toxicol In Vitro       Date:  2013-06-25       Impact factor: 3.500

Review 6.  New approaches from nanomedicine for treating leishmaniasis.

Authors:  Víctor Gutiérrez; Amedea B Seabra; Rosa M Reguera; Jayant Khandare; Marcelo Calderón
Journal:  Chem Soc Rev       Date:  2016-01-07       Impact factor: 54.564

Review 7.  Current scenario of drug development for leishmaniasis.

Authors:  Simon L Croft; Karin Seifert; Vanessa Yardley
Journal:  Indian J Med Res       Date:  2006-03       Impact factor: 2.375

Review 8.  Application of nanotechnology in treatment of leishmaniasis: A Review.

Authors:  Maryam Akbari; Ahmad Oryan; Gholamreza Hatam
Journal:  Acta Trop       Date:  2017-04-28       Impact factor: 3.112

9.  Efficacy of biogenic selenium nanoparticles against Leishmania major: in vitro and in vivo studies.

Authors:  Nasibeh Beheshti; Saied Soflaei; Mojtaba Shakibaie; Mohammad Hossein Yazdi; Fatemeh Ghaffarifar; Abdolhossein Dalimi; Ahmad Reza Shahverdi
Journal:  J Trace Elem Med Biol       Date:  2012-12-06       Impact factor: 3.849

10.  Metabolic, immune, and gut microbial signals mount a systems response to Leishmania major infection.

Authors:  Sabrina D Lamour; Kirill A Veselkov; Joram M Posma; Emilie Giraud; Matthew E Rogers; Simon Croft; Julian R Marchesi; Elaine Holmes; Karin Seifert; Jasmina Saric
Journal:  J Proteome Res       Date:  2014-11-24       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.